DZD3969

N/A

Report date: 2023/05/17 14:33:53
NME

Base Information

Drug NameDZD3969
Drug Alias NameDZD-3969DZD3969
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors degraders
TargetsEstrogen receptors
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesDizal (Jiangsu) Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDizal (Jiangsu) Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A